ArticleACS omega2026
Characterizing Family 1 Glycosyltransferases (GT1, UGT) by Reverse Glycosylation: Fast Determination of Acceptor Specificity, Donor Specificity, Hydrolysis, and Enzyme Stability.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Manufacturing glycoside conjugates through conventional chemistry is a labor-intensive process that involves multiple reaction steps, generates substantial toxic waste, and often results in low yields with poor control over regioselectivity. In contrast, glycosyltransferase family 1 enzymes offer an efficient alternative, enabling the transfer of glycosyl groups in a single step with excellent regioselective control and high yields. However, the factors governing acceptor specificity and the scope of individual enzymes remain unclear, limiting their broader application. To date, there is no widely implemented, low-cost approach to the high-throughput screening of these enzymes. Here, we use reverse glycosylation with 2-chloro-4-nitrophenyl-β-d-glycosides as a generic high-throughput screening method for UGT characterization. We investigate reverse glycosylation kinetics of 34 UGTs and their donor specificity toward the glucose and galactose moieties. Then, the method is utilized in an acceptor screening with 44 acceptors against 32 enzymes, and we determined the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.